Articles | EuroIntervention

Editorial

10.4244/EIJ-E-22-00023 • Aug 19, 2022

Defer-based non-stenting: a promising approach for STEMI

Jia H, He L

free

Editorial

10.4244/EIJ-E-22-00024 • Aug 19, 2022

ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike

Krucoff M, Cao D, Mehran R

free

EAPCI Column

10.4244/EIJ-E-22-00028 • Aug 19, 2022

EAPCI Presidential “criss-cross”

Barbato E, Dudek D

free

Viewpoint

10.4244/EIJ-D-22-00250 • Aug 19, 2022

Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?

Pelliccia F, Niccoli G

free

Expert consensus

10.4244/EIJ-D-22-00166 • Aug 19, 2022

Treatment of coronary bifurcation lesions, part II: implanting two stents. The 16th expert consensus document of the European Bifurcation Club

Lassen JF, Albiero R, Johnson T, Burzotta F, Lefèvre T, Iles TL, Pan M, Banning A, Chatzizisis Y, Ferenc M, Dzavik V, Milasinovic D, Darremont O, Hildick-Smith D, Louvard Y, Stankovic G

free

Clinical research

10.4244/EIJ-D-22-00135 • Aug 19, 2022

Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month DAPT trial

Lee Y, Cho JY, Yun KH, Lee S, Hong S, Ahn C, Kim B, Ko Y, Choi D, Hong M, Jang Y, Kim J

free

Clinical research

10.4244/EIJ-D-21-00950 • Aug 19, 2022

Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention

Madsen J, Kelbæk H, Nepper-Christensen L, Jacobsen M, Ahtarovski KA, Høfsten D, Holmvang L, Pedersen F, Tilsted H, Aarøe J, Jensen SE, Raungaard B, Terkelsen CJ, Køber L, Engstrøm T, Lønborg J

free

Clinical research

10.4244/EIJ-D-21-00766 • Aug 19, 2022

Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial

de Winter R, Zaman A, Hara H, Gao C, Ono M, Garg S, Smits PC, Tonino P, Hofma S, Moreno R, Choudhury A, Petrov I, Cequier A, Colombo A, Kaul U, Onuma Y, Serruys PW

free

Clinical research

10.4244/EIJ-D-21-01048 • Aug 19, 2022

Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2

Garot P, Neylon A, Morice M, Tamburino C, Bleiziffer S, Thiele H, Scholtz S, Schramm R, Cockburn J, Cunnington M, Wolf A, Barbanti M, Tchétché D, Pagnotta P, Gilard M, Bedogni F, Van Belle E, Vasa-Nicotera M, Chieffo A, Bogaerts K, Hengstenberg C, Capodanno D

free

Clinical research

10.4244/EIJ-D-21-00846 • Aug 19, 2022

Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial

Leurent G, Auffret V, Donal E, Corbineau H, Grinberg D, Bonnet G, Leroux P, Guérin P, Wautot F, Lefèvre T, Messika-Zeitoun D, Iung B, Armoiry X, Trochu J, Boutitie F, Obadia J

free

10.4244/EIJ-D-21-01009L • Aug 19, 2022

Letter: Caffeine and fractional flow reserve overestimation: a word of caution

Siig C, Ahmad M

free

10.4244/EIJ-D-21-01009R • Aug 19, 2022

Reply: Caffeine and fractional flow reserve overestimation: a word of caution

Matsumoto H

free

Aug 5, 2022

The 16th expert consensus from the European Bifurcation Club; ticagrelor or aspirin monotherapy 1 year after PCI; magnesium scaffolds in STEMI; the relationship between coronary vasospasm and atherosclerosis in ANOCA; lifetime valve journey with severe aortic stenosis; endovascular atherectomy in PAD; and more...including our new impact factor!

Capodanno D